Frederick W. Miller

34.6k total citations · 7 hit papers
436 papers, 19.7k citations indexed

About

Frederick W. Miller is a scholar working on Epidemiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Frederick W. Miller has authored 436 papers receiving a total of 19.7k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Epidemiology, 102 papers in Molecular Biology and 97 papers in Rheumatology. Recurrent topics in Frederick W. Miller's work include Inflammatory Myopathies and Dermatomyositis (176 papers), Eosinophilic Disorders and Syndromes (49 papers) and Immunodeficiency and Autoimmune Disorders (46 papers). Frederick W. Miller is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (176 papers), Eosinophilic Disorders and Syndromes (49 papers) and Immunodeficiency and Autoimmune Disorders (46 papers). Frederick W. Miller collaborates with scholars based in United States, Canada and United Kingdom. Frederick W. Miller's co-authors include Lisa G. Rider, Ira N. Targoff, Paul H. Plötz, Mark Worwood, Henry Metzger, Lori A. Love, Richard L. Leff, Terrance P. OʼHanlon, Marinos C. Dalakas and Chester V. Oddis and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Frederick W. Miller

419 papers receiving 18.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A New Approach to the Classification of Idiopathic Inflammatory Myopathy

1991 694 citations Ira N. Targoff, Frederick W. Miller et al. profile →
Serum ferritin concentration and iron stores in normal subjects

1973 505 citations Frederick W. Miller et al. profile →
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

2012 448 citations Rohit Aggarwal, Lisa G. Rider et al. profile →
Aristolochic acid and the etiology of endemic (Balkan) nephropathy

2007 448 citations Arthur P. Grollman, Shinya Shibutani et al. Proceedings of the National Academy of Sciences profile →
Ferritin in the Serum of Normal Subjects and Patients with Iron Deficiency and Iron Overload

1972 422 citations Frederick W. Miller et al. profile →
Idiopathic inflammatory myopathies

2021 347 citations Ingrid E. Lundberg, Rohit Aggarwal et al. profile →
The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention

2022 206 citations Frederick W. Miller profile →

Peers

Countries citing papers authored by Frederick W. Miller

Since Specialization

Citations

This map shows the geographic impact of Frederick W. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick W. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick W. Miller more than expected).

Fields of papers citing papers by Frederick W. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick W. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick W. Miller. The network helps show where Frederick W. Miller may publish in the future.

Co-authorship network of co-authors of Frederick W. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick W. Miller. A scholar is included among the top collaborators of Frederick W. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick W. Miller. Frederick W. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating Legacy and Emerging PFAS in Human Blood Collected from 2003 to 2021 2026 ·Environmental Science & Technology ·(unknown), (unknown), Kaylie I. Kirkwood‐Donelson, (unknown), Kakali Sarkar, (unknown), Frederick W. Miller, (unknown), (unknown), Alan K. Jarmusch, (unknown), (unknown)	0
2	Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis 2024 ·Arthritis Research & Therapy ·(unknown), James M. Ward, Kakali Sarkar, Adam Schiffenbauer, (unknown), Michael A. Smith, Saifur Rahman, Kamelia Zerrouki, Frederick W. Miller, Jian‐Liang Li, Kerry A. Casey, Lisa G. Rider	0
3	American College of Rheumatology White Paper: The Effects of Climate Change on Rheumatic Conditions—An Evolving Landscape and a Path Forward 2024 ·Arthritis & Rheumatology ·Paul F. Dellaripa, (unknown), Paul Bain, Cristina Lanata, Ashira Blazer, Frederick W. Miller, Candace H. Feldman	10
4	A Pilot Program Utilising a “Chatbot “ to Support Patients in the First 30 Days Following an Admission to Hospital With Acute Decompensated Heart Failure 2023 ·Heart Lung and Circulation ·G. Vaddadi, Frederick W. Miller, Naveen Sharma, (unknown), (unknown), (unknown), Joanne Taylor, W. van Gaal	1
5	Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis 2023 ·Arthritis & Rheumatology ·(unknown), Katherine Pak, Iago Pinal‐Fernandez, Willy A. Flegel, Ira N. Targoff, Frederick W. Miller, Lisa G. Rider, Andrew L. Mammen, (unknown)	9
6	Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review 2023 ·Clinical and Experimental Rheumatology ·Didem Saygın, (unknown), (unknown), Matteo Bottai, Marjolein Visser, Mazen M. Dimachkie, David Fiorentino, (unknown), Masataka Kuwana, Frederick W. Miller, Merrilee Needham, Lisa G. Rider, Yasser Salem, (unknown), Samuel Katsuyuki Shinjo, Guochun Wang, Victoria P. Werth, Rohit Aggarwal, Ingrid E. Lundberg	4
7	Reconstructing missing data by comparing interpolation techniques: Applications for long‐term water quality data 2023 ·Limnology and Oceanography Methods ·Danelle M. Larson, (unknown), (unknown), (unknown), (unknown), Frederick W. Miller, (unknown), Richard A. Erickson, (unknown)	12
8	Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey 2023 ·Preventive Medicine Reports ·Michael H. Weisman, (unknown), Hyun‐Seok Kim, Jason K. Hou, Frederick W. Miller, Charles Dillon	25
9	Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis 2023 ·Arthritis & Rheumatology ·James M. Ward, (unknown), Terrance P. OʼHanlon, Michael A. Smith, Melissa de los Reyes, Adam Schiffenbauer, Saifur Rahman, Kamelia Zerrouki, Frederick W. Miller, Miguel A. F. Sanjuán, Jian‐Liang Li, Kerry A. Casey, Lisa G. Rider	12
10	The Climate Emergency and the Health of Our Patients: The Role of the Rheumatologist 2022 ·Arthritis & Rheumatology ·Paul F. Dellaripa, Thomas Bush, Frederick W. Miller, Candace H. Feldman	9
11	The lupus susceptibility allele DRB103:01 encodes a disease-driving epitope 2022 ·Communications Biology* ·Bruna Miglioranza Scavuzzi, Vincent van Drongelen, (unknown), (unknown), Jianhua Liu, Raquel Agnelli Mesquita‐Ferrari, J. Michelle Kahlenberg, Evan A. Farkash, Fernando Benavides, Frederick W. Miller, Amr H. Sawalha, Joseph Holoshitz	12
12	A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients 2022 ·Lara D. Veeken ·(unknown), J Boehler, Ning Li, (unknown), Terrance P. OʼHanlon, Eric P. Hoffman, Jennifer M. Peterson, Frederick W. Miller, Lisa G. Rider, (unknown)	2
13	Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis 2021 ·Arthritis & Rheumatology ·Iago Pinal‐Fernandez, Katherine Pak, Albert Gil‐Vila, (unknown), (unknown), María Casal-Domínguez, Assia Derfoul, (unknown), Albert Selva-O’Callaghan, (unknown), Livia Casciola‐Rosen, Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Sonye K. Danoff, Thomas E. Lloyd, Frederick W. Miller, Lisa G. Rider, Lisa Christopher‐Stine, Andrew L. Mammen, (unknown)	6
14	CD3Zhypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ζ-chain expression in T cells 2016 ·Lara D. Veeken ·(unknown), Hyun Kyoung Kim, (unknown), (unknown), Mi Kyung Kim, Joohon Sung, Betty P. Tsao, Jennifer M. Grossman, Ornella J. Rullo, Jennifer M. P. Woo, Deborah McCurdy, Lisa G. Rider, Frederick W. Miller, (unknown)	15
15	Forkhead Transcription Factor Foxq1 Promotes Epithelial–Mesenchymal Transition and Breast Cancer Metastasis 2011 ·Cancer Research ·Haijun Zhang, Fanyan Meng, Gang Liu, Bin Zhang, Jun Zhu, Feng Wu, Stephen P. Ethier, Frederick W. Miller, Guojun Wu	150
16	Development of Hepatocellular Carcinoma in Iqgap2 -Deficient Mice Is IQGAP1 Dependent 2008 ·Molecular and Cellular Biology ·Valentina A. Schmidt, (unknown), Encarnación Capilla, Frederick W. Miller, Wadie F. Bahou	105
17	Aristolochic acid and the etiology of endemic (Balkan) nephropathy breakdown → 2007 ·Proceedings of the National Academy of Sciences ·Arthur P. Grollman, Shinya Shibutani, Masaaki Moriya, Frederick W. Miller, Lin Wu, Ute M. Moll, Naomi Suzuki, Andrea Fernandes, Thomas A. Rosenquist, Zvonimir Medverec, Krunoslav Jakovina, Branko Brdar, Neda Slade, Robert J. Turesky, Angela K. Goodenough, Robert Rieger, Mato Vukelić, Bojan Jelaković	448
18	Inhibition of breast cancer progression by a medicinal herb Ocimum sanctum 2006 ·Cancer Research ·Pratima Nangia‐Makker, Larry Tait, Victor Hogan, Frederick W. Miller, Avraham Raz	2
19	Silicone gel-filled breast and testicular implant capsules: a histologic and immunophenotypic study. 1999 ·PubMed ·Susan L. Abbondanzo, Vivienne L. Young, (unknown), Frederick W. Miller	39
20	Antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with dextran-anti-dextran immune complexes. 1983 ·PubMed Central ·Kim L. Isaacs, Frederick W. Miller	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact